Murine cytomegalovirus induces expression and enzyme activity of cellular dihydrofolate reductase in quiescent cells

Journal of General Virology

Volumn 79, Issue 11, 1998, Pages 2803-2807

  Lembo, David ^a   Angeretti, Alessandra ^a   Gariglio, Marisa ^b   Landolfo, Santo ^c  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ENZYME; DIHYDROFOLATE REDUCTASE; DNA POLYMERASE; IMMEDIATE EARLY PROTEIN; METHOTREXATE; NUCLEOSIDE TRIPHOSPHATE; VIRUS ENZYME;

ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CYTOMEGALOVIRUS; ENZYME INDUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; CYTOMEGALOVIRUS; DNA VIRUSES; MAIZE CHLOROTIC MOTTLE VIRUS; MOUSE CYTOMEGALOVIRUS 1; MURINAE;

EID: 0031736036     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-79-11-2803     Document Type: Article

References (35)

1. Abken, H. & Reifenrath, B. (1992). A procedure to standardize CAT reporter gene assay. Nucleic Acids Research 20, 3527.
2. Allegra, C. J., Chabner, B. A., Tuazon, C. U., Ogata-Arakaki, D., Baird, B., Drake, J. C., Simmons, J. T., Lack, E. E., Shelhamer, J. H., Balis, F., Walker, R., Kovacs, J. A., Lane, H. C. & Masur, H. (1987). Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. New England Journal of Medicine 317, 978-985.
3. Baldanti, F., Underwood, M. R., Stanat, S. C., Biron, K., Chou, S., Sarasini, A., Silini, E. & Gerna, G. (1996). Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow growth phenotype, while mutation in the UL97-encoded phosphotransferase confer ganciclovir resistance in three-double resistant human cytomegalovirus strains recovered from patients with AIDS. Journal of Virology 70, 1390-1395.
4. Bean, B. (1992). Antiviral therapy: current concept and practices. Clinical Microbiology Reviews 5, 146-182.
5. Bertino, J. R. (1993). Karnofski Memorial Lecture: Ode to methotrexate. Journal of Clinical Oncology 11, 5-14.
6. Boldogh, I., AbuBakar, S., Millinoff, D., Deng, C. Z. & Albrecht, T. (1991). Cellular oncogenes activation by human cytomegalovirus. Lack of correlation with virus infectivity and immediate early gene expression. Archives of Virology 118, 163-177.
7. Burns, L. J., Waring, F., Reuter, J. J., Stinski, M. F. & Ginder, G. (1993). Only the HLA class I minimal promoter elements are required for transactivation by human cytomegalovirus immediate early genes. Blood 81, 1558-1566.
8. Chou, S., Erice, A., Jordan, C. M., Vercellotti, G. M., Michelis, K. R., Talarico, C. L., Stanat, S. C. & Biron, K. (1995). Analysis of UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutation conferring ganciclovir resistance. Journal of Infectious Disease 171, 576-583.
9. Colberg-Poley, A. M., Santomenna, L. D., Harlow, P. P., Benfield, P. & Tenney, D. J. (1992). Human cytomegalovirus US3 and UL36-38 immediate-early proteins regulate gene expression. Journal of Virology 66, 95-105.
10. Dittmer, D. & Mocarski, E. S. (1997). Human cytomegalovirus infection inhibits G1/S transition. Journal of Virology 71, 1629-1634.
11. Dudding, L., Haskill, S., Clark, B. D., Auron, P. E., Sporn, S. & Huang, E. S. (1989). Cytomegalovirus infection stimulates expression of monocyte-associated mediator genes. Journal of Immunology 10, 3343-3352.
12. Fallon, J., Allegra, C., Kovacs, J., O'Neill, D., Ogata-Arakaki, D., Feuerstein, I., Polis, M., Davey, R., Lane, H. C., LaFon, S., Rogers, M., Zunich, M., Zurlo, J., Tuazon, C., Parenti, D., Simon, G. & Masur, H. (1990). Piritrexim with leucovorin for the treatment of pneumocystis pneumonia (PCP) in AIDS patients. Clinical Research 38, 361A.
13. Fleming, G. F. & Schilsky, R. L. (1992). Antifolates: the next generation. Seminars in Oncology 19, 707-719.
14. Furukawa, T., Fioretti, A. & Plotkin, S. A. (1973). Growth characteristics of cytomegalovirus in human fibroblasts with demonstration of protein synthesis early in viral replication. Journal of Virology 11, 991-997.
15. Furukawa, T., Tanaka, S. & Plotkin, S. A. (1975). Stimulation of macromolecular synthesis in guinea pig cells by human CMV. Proceedings of the Society for Experimental Biology and Medicine 148, 211-214.
16. Gariglio, M., Foresta, P., Sacchi, C., Lembo, M., Hertel, L. & Landolfo, S. (1997). Suppression of high mobility group protein T160 expression impairs mouse cytomegalovirus replication. Journal of General Virology 78, 665-670.
17. Geist, L. J., Monik, M. M., Stinski, M. F. & Hunninghake, G. (1993). The immediate-early genes of human cytomegalovirus upregulate tumor necrosis factor-α gene expression. Journal of Clinical Investigation 93, 474-478.
18. Hayhurst, G. P., Bryant, L. A., Caswell, R. C., Walker, S. M. & Sinclair, J. H. (1995). CCAAT box-dependent activation of the TATA-less human DNA polymerase a promoter by the human cytomegalovirus 72-kilodalton major immediate-early protein. Journal of Virology 69, 182-188.
19. Hitchings, G. H. (1978). The metabolism of plasmodia and the chemotherapy of malaria infections. In Tropical Medicine from Romance to Reality p. 79-98. Edited by R. J. Wood. London: Academic Press.
20. Huang, E. S. & Kovalik, T. F. (1993). The pathogenicity of human cytomegalovirus: an overview. In Molecular Aspects of Human Cytomegalovirus Diseases, pp. 1-45. Edited by Y. Becker, G. Darai & E.-S. Huang. Berlin: Springer-Verlag.
21. Johnson, L. F., Fuhrman, L. G. & Weidemann, L. M. (1978). Regulation of dihydrofolate reductase gene expression in mouse fibroblasts during the transition from resting to growing state. Journal of Cellular Physiology 97, 397-406.
22. r murine cytomegalovirus immediate-early protein activates gene transcription. Journal of Virology 58, 59-66.
23. Kuyper, L. F., Baccanari, D. P., Jones, M. L., Hunter, R. N., Tansik, R. L., Joyner, S. S., Boytos, C. M., Rudolph, S. K., Knick, V., Wilson, H. R., Caddell, J. M., Friedman, H. S., Comley, J. C. W. & Stables, J. M. (1996). High-affinity inhibitors of dihydrofolate reductase: antimicrobial and anticancer activities of 7,8-dialkyl-1,3-diaminolpyrrolo[3,2-f] quinazolines with small molecular size. Journal of Medicinal Chemistry 39, 892-903.
24. Margolis, M. J., Pajovic, S., Wong, E. L., Wade, M., Jupp, R., Nelson, J. A. & Azizkhan, J. C. (1995). Interaction of the 72-kilodalton human cytomegalovirus IE1 gene product with E2F1 coincides with E2F-dependent activation of dihydrofolate reductase transcription. Journal of Virology 69, 7759-7767.
25. Nicholas, J., Ruvolo, V., Zong, J., Ciufo, D., Guo, H. G., Reitz, M. S. & Hayward, G. S. (1997). A single 13-kilobase divergent locus in the Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genome contains nine open reading frames that are homologous to or related to cellular proteins. Journal of Virology 71, 1963-1974.
26. Rawlinson, W. D., Farrell, H. E. & Barrell, B. G. (1996). Analysis of the complete DNA sequence of murine cytomegalovirus. Journal of Virology 70, 8833-8849.
27. Rothenberg, S. P. (1966). A rapid radioassay for folic acid reductase and amethopterin. Analytical Biochemistry 16, 176-179.
28. Salter, A. J. (1982). Trimethoprim-sulfamethoxazole: an assessment of more than 12 years of use. Review of Infectious Disease 4, 196-236.
29. r murine cytomegalovirus immediate-early protein stimulates c-fos expression and cellular DNA synthesis. Journal of Virology 62, 3341-3347.
30. Schweitzer, B. I., Dicker, A. P. & Bertino, J. R. (1990). Dihydrofolate reductase as a therapeutic target. FASEB Journal 4, 2441-2452.
31. Shanley, J. D. & Debs, R. J. (1989). The folate antagonist, methotrexate, is a potent inhibitor of murine and human cytomegalovirus in vitro. Antiviral Research 11, 99-106.
32. Tanaka, S., Furukawa, T. & Plotkin, S. A. (1975). Human cytomegalovirus stimulates host cell RNA synthesis. Journal of Virology 15, 297-304.
33. Trimble, J. J., Shridhara, C. S., Bakker, M. A., Grassmann, R. & Desrosiers, R. C. (1988). A gene for dihydrofolate reductase in a herpesvirus. Science 239, 1145-1147.
34. Wachsman, M., Hamzeh, F. M., Saito, H. & Lietman, P. S. (1996). Anticytomegaloviral activity of methotrexate associated with preferential accumulation of drug by cytomegalovirus-infected cells. Antimicrobial Agents and Chemotherapy 40, 433-436.
35. Wade, M., Kowalik, T. F., Mudryj, M., Huang, E. S. & Azizkhan, J. C. (1992). E2F mediates dihydrofolate reductase promoter activation and multiprotein complex formation in human cytomegalovirus infection. Molecular and Cellular Biology 12, 4364-4374.